As part of our continuous effort to test the existence of factor premiums off the beaten track of global equities, we have investigated whether well-known factor premiums such as size, low risk, value and momentum can also be found in emerging market corporate bonds.
Using the generic factor definitions from our award-winning research paper on factor investing in developed market (DM) corporate bonds1, this new research2 shows that allocating to size, low risk, value and momentum in emerging market (EM) credits yields significantly positive risk-adjusted returns, with Sharpe ratios ranging from 0.57 to 0.85 versus 0.37 for the market.
More specifically, portfolios based on size, value and momentum significantly outperform the market. Meanwhile, a portfolio based on the low-risk factor delivers a return that is close to the market’s, but with roughly a third of the volatility.
Controlling for market exposures, we found alphas that are economically meaningful and statistically significant, with annualized CAPM alphas ranging between 1.46% and 5.03%. We also found that a multi-factor portfolio that allocates equally to the four factors obtains an information ratio of 1.19, which is higher and more significant than the information ratios obtained by single-factor portfolios.
Our research also shows that allocating to factors in the EM credit market is attractive, even for investors who already allocate to factors in DM credit or equity markets. All the factor portfolios have significantly positive alphas after controlling for DM credit or equity factors. Interestingly, the size and momentum EM credit factor portfolios show a statistically significant relationship with their DM credit counterparts and, therefore, seem to benefit from broader factor premiums.
Part of the risk-adjusted outperformances of the factor portfolios is driven by bottom-up country allocation. When we constructed country-neutral factor portfolios, we found that the Sharpe ratios and, except in the case of low risk, alphas decline. The Sharpe ratio of the multi-factor portfolio declines from 0.73 to 0.66, but remains highly significant; as too does the alpha controlled for exposures to DM credit factors, which declines from 2.45% to 1.84%.
These results indicate that factor premiums exist both within and across EM countries
These results indicate that factor premiums exist both within and across EM countries. In addition to being robust within countries, our results are robust and hold within sectors, ratings, maturity segments and liquidity segments. In other checks, we found that our results are also robust to portfolio construction choices.
In short, our new research confirms the existence of factor premiums in EM credits and serves as a true out-of-sample test of our earlier research on DM credits. What is more, these factor premiums are largely unique to EM because they cannot be explained by exposures to DM factors or equity factors. A variety of sensitivity analyses show that the premiums are robust and can be found in subsegments of the market.
Read the related working paper on SSRN.
1 Houweling, P. and Van Zundert, J., 2017, ‘Factor investing in the corporate bond market’, Financial Analysts Journal.
2 Dekker, L., Houweling, P. and Muskens, F., 2019, ‘Factor investing in emerging market credits’, working paper.
The information contained in the website is solely intended for professional investors. Some funds shown on this website fall outside the scope of the Dutch Act on the Financial Supervision (Wet op het financieel toezicht) and therefore do not (need to) have a license from the Authority for the Financial Markets (AFM).
The funds shown on this website may not be available in your country. Please select your country website (top right corner) to view the products that are available in your country.
Neither information nor any opinion expressed on the website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports, which can be all be obtained free of charge at this website and at the Robeco offices in each country where Robeco has a presence.